Infinity Pharmaceuticals
(OTC) INFI
Infinity Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.57M
Net Income (TTM)
$39.91M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
INFI News
INFI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Infinity Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
30
CEO
Adelene Q. Perkins, MBA
Website
www.infi.comHeadquarters
Cambridge, MA 02138, US
INFI Financials
Key Financial Metrics (TTM)
Gross Margin
40%
Operating Margin
-17%
Net Income Margin
-17%
Return on Equity
-35%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.03M
Operating Income
$44.84M
EBITDA
$43.73M
Operating Cash Flow
$42.43M
Capital Expenditure
$17.00K
Free Cash Flow
$42.45M
Cash & ST Invst.
$38.31M
Total Debt
$917.00K
Infinity Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$583.00K
-15.0%
Gross Profit
$231.00K
-15.1%
Gross Margin
39.62%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
30
N/A
Net Income
$9.96M
+16.7%
EBITDA
$9.80M
+17.1%
Quarterly Fundamentals
Net Cash
$17.11M
-69.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$633.00K
+14.1%
Return on Assets
-1.05%
N/A
Return on Invested Capital
-1.57%
N/A
Free Cash Flow
$8.01M
+24.4%
Operating Cash Flow
$8.01M
+24.4%